Bualan, Casandra Eve L.

HRN: 03-90-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2024
CEFUROXIME 500MG (TAB)
03/30/2024
04/06/2024
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: